Stock Track | Fresenius Medical Care Plummets 6.84% Intraday on Earnings Miss and US Treatment Volume Decline
Stock Track
May 05
Fresenius Medical Care AG & Co. KGaA's stock plummeted 6.84% during intraday trading on Tuesday.
The sharp decline follows the company's release of first-quarter results that missed analyst estimates for both earnings per share and revenue. Additionally, the company reported a decrease in treatment volumes within its key US dialysis operations, with US same-market treatment volumes declining 0.4% year-over-year. Restructuring expenses related to a transformation program in the US also contributed to a lower net profit compared to the same period last year.
Analysts highlighted the decline in US treatment volumes as a key area of investor focus. Despite the quarterly challenges, the company confirmed its full-year financial guidance.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.